Blood Glucose Control

By Stanley S. Schwartz, MD and Mary E Herman, PhD

Despite guidelines, hypoglycemia can largely be avoided without shortchanging tight glucose control.

Screening, treatment delay may hasten or increase cardiovascular disease risk.

Man, 52 years of age, with obesity and type 2 diabetes, was switched from daily liraglutide (Victoza) 1.8mg to weekly semaglutide (Ozempic) 0.25mg. I was very clear with patient about the switch being from a daily injection to a weekly and that we would be increasing the semaglutide weekly.

Prospective study evaluates use of nasal glucagon for treatment of moderate to severe hypoglycemia in adults with type 2 diabetes.

Study finds higher hospital admissions, complications, and mortality rates among patients with increased A1c.

Guest Post by David Kliff, Editor, Diabetic Investor
Senseonics has taken their Eversense implantable CGM before an FDA panel, and Bigfoot has announced they have closed their series B $55 million financing round. The FDA has approved Dexcom’s G6 system, pushing shares in the company higher in early trading. And while they didn’t announce anything recently, our friends at Tandem are feeling the love as shares continue to surge higher in anticipation of their new system, which has low glucose suspend.

Organization says adults with type 2 diabetes can aim for an easier-to-achieve blood sugar target than what’s been used to guide treatment in the past.

When added to statin therapy in patients with diabetes, ezetimibe provides greater cardiovascular protection than what is seen in individuals without diabetes.

Patch delivery system shows promise as a new developing treatment option for diabetes.

Low Fat-Vegetarian-Vegan diet shown to improve glucose control, slow diabetes progression.